Norgine Ventures completes financing with Lunaphore
Lunaphore Technologies SA, a privately owned Swiss company spun out from EPFL, develops automated tissue stainers which enable translational research laboratories to rapidly generate highly-multiplexed spatial biology assays using standard antibody libraries, with no conjugation or barcoding needed. Lunaphore’s most advanced solution, the COMET, is a fully automated sequential multiplex instrument, able to carry out staining, microscope imaging, and image analysis, producing high quality data without human intervention.
Norgine Ventures provided Lunaphore with a Bond facility in April 2022
